methyl 5-aminolevulinate has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassano, N; Fai, D; Romano, I; Vena, GA | 1 |
1 other study(ies) available for methyl 5-aminolevulinate and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Cutaneous lupus erythematosus of the scalp treated with methyl-aminolevulinate photodynamic therapy: a case report.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Aminolevulinic Acid; Comorbidity; Contraindications; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Male; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses | 2012 |